News Archive

Feb 2015

Feb 17, 2015 Starpharma presents at ASX Investor Series

Feb 16, 2015 Interim Report and Half-Year Financial Results

Jan 2015

Jan 28, 2015 Quarterly Cashflow Report

Jan 12, 2015 Starpharma to present at Biotech Showcase

Dec 2014

Dec 05, 2014 Japan VivaGel® condom launch timing impacted by classification review

Nov 2014

Nov 28, 2014 Marketing Clearance for VivaGel® condom in New Zealand

Nov 13, 2014 Starpharma’s Priostar® Glyphosate Patent Allowed in China

Oct 2014

Oct 31, 2014 Appendix 4C - Quarterly Cashflow Statement

Oct 30, 2014 Starpharma raises $3.5M through SPP following $18M Placement

Oct 29, 2014 Starpharma receives $4.2 million R&D tax incentive refund

Oct 29, 2014 VivaGel® condom now available in Australian stores

Oct 21, 2014 Starpharma Boardroom Radio Interview

Oct 20, 2014 Extension of Share Purchase Plan

Oct 20, 2014 DEP™ docetaxel shows intended longer duration and increased exposure

Oct 14, 2014 Starpharma to present at US Drug Delivery Conference

Oct 07, 2014 Shareholder Update October 2014

Oct 02, 2014 VivaGel® condom approved for sale with launch imminent

Sep 2014

Sep 22, 2014 Starpharma completes A$18 million placement - SPP to follow

Aug 2014

Aug 13, 2014 Annual Report and full year financial results

Aug 07, 2014 The Business on ABC TV: Interview with Starpharma CEO Jackie Fairley

Aug 07, 2014 Glamour UK: Potential Huge News: This New Condom May Be Able to Kill HIV, Herpes, and Other STDs

Aug 07, 2014 The Washington Times: HIV-killing condom to soon hit shelves in Australia

Aug 07, 2014 The Daily Mail: First condom designed to kill HIV "could be available to buy within months"

Aug 07, 2014 Elite Daily: The Future of Safe Sex: New Condom in Australia is covered with an HIV-killing lubricant

Aug 07, 2014 ABC: Starpharma and Ansell get approval for HIV-killing condom

Aug 07, 2014 AFR: Virus killing condom to hit shelves

Jul 2014

Jul 31, 2014 Appendix 4C - Quarterly Cashflow Statement

Jul 21, 2014 VivaGel® condom receives TGA device certification - Launch preparations to follow

Jul 14, 2014 FDA Grants SPA Agreement for Phase 3 Recurrent BV Trial

Jun 2014

Jun 13, 2014 Rob Thomas succeeds retiring Chairman Peter Bartels

Jun 12, 2014 Shareholder Update: June 2014

Jun 05, 2014 Starpharma's clinical trial programs accelerating

Apr 2014

Apr 30, 2014 Appendix 4C - Quarterly Cashflow Report

Apr 10, 2014 The Business on ABC TV: Interview with Starpharma CEO Jackie Fairley

Apr 07, 2014 Starpharma expands its Drug Delivery Program with AstraZeneca

Mar 2014

Mar 14, 2014 VivaGel®-coated condom approved for marketing in Japan

Mar 11, 2014 Starpharma receives $4.7M R&D tax incentives

Feb 2014

Feb 27, 2014 Starpharma to present to US institutional investors

Feb 24, 2014 Starpharma Interim Report and Half-year Financial Results

Jan 2014

Jan 30, 2014 Appendix 4C - Quarterly Cashflow Report

Jan 23, 2014 Starpharma commences Dendrimer-Docetaxel clinical trial

Jan 14, 2014 Starpharma to recoup additional $2 million for overseas R&D

Dec 2013

Dec 19, 2013 Cancer Australia funding for dendrimer-based lung treatment

Dec 17, 2013 Shareholder Update: December 2013

Dec 05, 2013 Appointment of Rob Thomas as a Director

Nov 2013

Nov 22, 2013 AGM Chair address & CEO presentation; Results of meeting

Nov 20, 2013 Australian Financial Review: Biotech sector revival as appetite for risk grows

Nov 11, 2013 Starpharma new Board appointment

Oct 2013

Oct 28, 2013 Appendix 4C - Quarterly Cashflow Report

Oct 24, 2013 Starpharma's Dendrimer-Docetaxel eliminates neutropenia